ÿþ<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"> <html> <head> <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"> <title>EASL 2010 - Poster Presentations</title> <link rel="stylesheet" type="text/css" href="style.css"> </head> <body> <table width="750" align="center" border="0" cellspacing="0" cellpadding="0" class="MainTable"> <tr> <td><img src="http://www2.kenes.com/liver-congress/PublishingImages/top_ei.jpg" width="760" height="129" /></td> </tr> <tr> <td class="content"><h1>Poster Presentations</h1> <P><b><u>Apr 17, 2010</u></b></P><p align=right><em>Poster Board Number</em></p><H2>Category 3a. LIVER TUMORS: a. EXPERIMENTAL:<br /></H2><table><tr> <td><a href='Abstract747.htm'><B>SYNERGISTIC ANTITUMORAL EFFECT OF SUBCUTANEOUS INOCULATION WITH AFP-PULSED DC COMBINED WITH INTRATUMORAL INJECTION OF CD40L-EXPRESSING DC IN ESTABLISHED HEPATOCELLULAR TUMORS (HCC) <I>IN VIVO</I></B></a> </em><br> <b>T. Ayub</b><sup>1</sup>*, A. Vogt<sup>1</sup>, W.H. Caselmann<sup>2</sup>, T. Sauerbruch<sup>1</sup>, M.A. González-Carmona<sup>1</sup><br> <em><sup>1</sup>University of Bonn, Internal Medicine, Bonn, <sup>2</sup>Ministry of the Environment and Public Health, Bavarian State, Munich, Germany. *tiyashahosne@yahoo.de</em></td><td valign=top><em>860 </td></tr> <tr> <td><a href='Abstract748.htm'><B>EXTENDED LOW-DOSE METRONOMIC CHEMOTHERAPY IN RATS WITH CHEMICALLY INDUCED HEPATOCELLULAR CARCINOMA</B></a> </em><br> J.W. Jang<sup>1</sup>, S.T. Park<sup>2</sup>, G.D. Kim<sup>2</sup>, J.Y. Choi<sup>1</sup>, S.K. Yoon<sup>1</sup>, K.W. Chung<sup>1</sup>, <b>S.H. Bae</b><sup>1</sup>*<br> <em><sup>1</sup>Internal Medicine, <sup>2</sup>WHO Collaborating Center for Reference and Research on Viral Hepatitis, The Catholic University of Korea, Seoul, Republic of Korea. *garden@catholic.ac.kr</em></td><td valign=top><em>861 </td></tr> <tr> <td><a href='Abstract749.htm'><B>DECREASED EXPRESSION OF MIR-199A-5P CONTRIBUTES TO INCREASED CELL INVASION BY FUNCTIONAL DEREGULATION OF <I>DDR1</I> ACTIVITY IN HEPATOCELLULAR CARCINOMA</B></a> </em><br> Q. Shen<sup>1</sup>, <b>S. Beckebaum</b><sup>1,2</sup>*, S. Iacob<sup>1,2,3</sup>, F. Weber<sup>2</sup>, C.G. Klein<sup>1,2</sup>, A. Paul<sup>2</sup>, G. Gerken<sup>1</sup>, V.R. Cicinnati<sup>1,2</sup><br> <em><sup>1</sup>Department of Gastroenterology and Hepatology, <sup>2</sup>Department of General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany, <sup>3</sup>Fundeni Clinical Institute of Digestive Diseases and Liver Transplantation, Bucharest, Romania. *susanne.beckebaum@uni-due.de</em></td><td valign=top><em>862 </td></tr> <tr> <td><a href='Abstract750.htm'><B>HEPATOCYTE-SPECIFIC DELETION OF MCL-1 INDUCES HEPATOCELLULAR PROLIFERATION AND SPONTANEOUS HEPATOCARCINOGENESIS</B></a> </em><br> <b>R.J. Boger</b><sup>1</sup>*, A. Weber<sup>2</sup>, B. Vick<sup>1</sup>, T. Urbanik<sup>1</sup>, B. Köhler<sup>1</sup>, A. Teufel<sup>1</sup>, P.R. Galle<sup>1</sup>, J. Haybäck<sup>3</sup>, S. Zoller<sup>4</sup>, M. Heikenwälder<sup>5</sup>, M. Schuchmann<sup>1</sup>, H. Schulze-Bergkamen<sup>6</sup><br> <em><sup>1</sup>Universitätsmedizin Mainz, Mainz, Germany, <sup>2</sup>Department of Pathology, University Hospital Zurich, <sup>3</sup>Department of Pathology, University of Zürich, Zürich, <sup>4</sup>4Functional Genomics Center Zurich, <sup>5</sup>Department of Pathology, University of Zürich, Zurich, Switzerland, <sup>6</sup>Nationales Centrum für Tumorerkrankungen Heidelberg, Heidelberg, Germany. *rboger1@gmail.com</em></td><td valign=top><em>863 </td></tr> <tr> <td><a href='Abstract751.htm'><B>COMBINING SUBCUTANEOUS INOCULATION OF AFP-EXPRESSING DC WITH INTRAPERITONEAL INJECTION OF IL-12-EXPRESSING DC INCREASES SURVIVAL IN AN ESTABLISHED ORTHOTOPIC HCC MODEL </B></a> </em><br> <b>G. Decker</b><sup>1</sup>*, A. Vogt<sup>1</sup>, I. Bahadori<sup>1</sup>, E. Raskopf<sup>1</sup>, V. Schmitz<sup>1</sup>, T. Sauerbruch<sup>1</sup>, W.H. Caselmann<sup>2</sup>, M.A. Gonzalez-Carmona<sup>1</sup><br> <em><sup>1</sup>Internal Medicine I, University of Bonn, Bonn, <sup>2</sup>Ministry of the Environment and Public Health, Bavarian State, Munich, Germany. *creager@web.de</em></td><td valign=top><em>864 </td></tr> <tr> <td><a href='Abstract752.htm'><B>NOTCH1 FUNCTIONS AS A TUMOR SUPPRESSOR IN LIVER SINUSOIDAL ENDOTHELIAL CELLS AND ITS DISRUPTION LEADS TO HEPATIC ANGIOSARCOMA IN A DIETHYLNITROSAMINE-INDUCED CANCER MODEL</B></a> </em><br> <b>M.T. Dill</b><sup>1</sup>*, L. Tornillo<sup>2</sup>, S. Rothweiler<sup>1</sup>, L. Terracciano<sup>2</sup>, M.H. Heim<sup>1,3</sup>, D. Semela<sup>1,3</sup><br> <em><sup>1</sup>Department of Biomedicine, University Basel, <sup>2</sup>Institute of Pathology, <sup>3</sup>Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland. *michael.dill@unibas.ch</em></td><td valign=top><em>865 </td></tr> <tr> <td><a href='Abstract753.htm'><B>IDENTIFICATION OF NOVEL CELLULAR TARGETS IN HUMAN INTRAHEPATIC CHOLANGIOCARCINOMA USING LASER MICRODISSECTION AND AMT-TAG PROTEOMICS</B></a> </em><br> <b>A. Dos Santos</b><sup>1,2</sup>*, M. Court<sup>3,4,5</sup>, V. Thiers<sup>1,2,6</sup>, S. Sar<sup>1,2</sup>, C. Guettier<sup>1,2,7</sup>, D. Samuel<sup>1,2,8</sup>, C. Brechot<sup>1,2,9</sup>, J. Garin<sup>3,4,5</sup>, F. Demaugre<sup>1,2</sup>, C. Masselon<sup>3,4,5</sup><br> <em><sup>1</sup>Unite 785, INSERM, <sup>2</sup>UMR-S785, Univ Paris-Sud, Villejuif, <sup>3</sup>DSV, iRTSV, Laboratoire d'Etude de la Dynamique des Protéomes, CEA, <sup>4</sup>Unite 880, INSERM, Grenoble, <sup>5</sup>Université Joseph Fourier, <sup>6</sup>Departement de Virologie, Institut Pasteur, Villejuif, <sup>7</sup>Service d'Anatomie Pathologique, AP-HP Hopital de Bicetre, Le Kremlin-Bicêtre, <sup>8</sup>Centre Hepato-Biliaire, AP-HP Hopital Paul Brousse, Villejuif, <sup>9</sup>Merieux Alliance, Lyon, France. *alexandre.dos-santos@inserm.fr</em></td><td valign=top><em>866 </td></tr> <tr> <td><a href='Abstract754.htm'><B>THE ROLE OF MICRORNA-125B REPRESSION IN THE PATHOGENESIS OF HEPATOCELLULAR CARCINOMA</B></a> </em><br> <b>N. Elfimova</b><sup>1</sup>*, M. Quasdorff<sup>2</sup>, I. Strack<sup>1</sup>, A. Noetel<sup>1</sup>, J. Riemer<sup>1</sup>, T. Goeser<sup>2</sup>, M. Kwiecinski<sup>1</sup>, U. Protzer<sup>2</sup>, H.-P. Dienes<sup>1</sup>, M. Odenthal<sup>1</sup><br> <em><sup>1</sup>Institute for Pathology, <sup>2</sup>Department of Gastroenterology and Hepatology, University Hospital of Cologne, Cologne, Germany. *natalia.elfimova@yahoo.de</em></td><td valign=top><em>867 </td></tr> <tr> <td><a href='Abstract755.htm'><B>STROMAL-DERIVED FACTOR-1 (SDF-1) - CXCR4 AXIS HAS AN IMPORTANT ROLE ON THE INTERACTION OF HUMAN HEPATIC STELLATE CELLS (HHSC) AND CC CELL LINES </B></a> </em><br> <b>A. Gentilini</b>*, K. Rombouts, S. Galastri, T. Mello, M. Brogi, A. Caligiuri, F. Marra, M. Pinzani<br> <em>Medicina Interna, Università degli Studi di Firenze, Firenze, Italy. *gen-ale@libero.it</em></td><td valign=top><em>868 </td></tr> <tr> <td><a href='Abstract756.htm'><B>HEPATIC STELLATE CELLS PROMOTE HCC PROGRESSION BY SECRETING LAMININ-5</B></a> </em><br> A. Santamato<sup>1</sup>, E. Fransvea<sup>1</sup>, A. Caligiuri<sup>2</sup>, F. Dituri<sup>1</sup>, M. Pinzani<sup>2</sup>, S. Antonaci<sup>1</sup>, <b>G. Giannelli</b><sup>1</sup>*<br> <em><sup>1</sup>Internal Medicine, Immunology and Infectious Disease, Section of Internal Medicine, University of Bari, Bari, <sup>2</sup>Department of Internal Medicine, Center for Research, High Education and Transfer  DENOThe , University of Florence, Florence, Italy. *g.giannelli@intmed.uniba.it</em></td><td valign=top><em>869 </td></tr> <tr> <td><a href='Abstract757.htm'><B>EPIGENETIC REGULATION OF CELLULAR TARGET GENES BY HBX: A CHROMATIN-IMMUNOPRECIPITATION (CHIP AND CHIP-SEQ) STUDY TO DEFINE THE HBX TRANSCRIPTOME IN HBV REPLICATING HCC CELLS</B></a> </em><br> <b>F. Guerrieri</b><sup>1,2,3</sup>*, L. Belloni<sup>1,2</sup>, V. Schinzari<sup>1,2</sup>, C.S. Scisciani<sup>1,2</sup>, T. Pollicino<sup>4</sup>, G. Raimondo<sup>4</sup>, M. Levrero<sup>1,2,3</sup><br> <em><sup>1</sup>Dept of Internal Medicine and AIRC Rome Oncogenomic Center (ROC), Sapienza, University of Rome, <sup>2</sup>Laboratory of Gene Expression, Fondazione A Cesalpino, Rome, Italy, <sup>3</sup>EAL U785, INSERM, Rome/Villejuif, France, <sup>4</sup>Dept of Internal Medicine, Universita' di Messina, Messina, Italy. *fraguerrieri@gmail.com</em></td><td valign=top><em>870 </td></tr> <tr> <td><a href='Abstract758.htm'><B>AN UNKNOWN TRANSCRIPTION FACTOR UP-REGULATED BY ESTROGEN MAY BE INVOLVED IN SEXUAL DIFFERENCE IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV-INFECTED PATIENTS THROUGH OSTEOPONTIN EXPRESSION</B></a> </em><br> <b>K. Hamaoka</b><sup>1</sup>*, S. Nagoshi<sup>1</sup>, K. Sugawara<sup>1</sup>, M. Inao<sup>1</sup>, K. Naiki<sup>1</sup>, N. Nakayama<sup>1</sup>, K. Fujiwara<sup>2</sup>, S. Mochida<sup>1</sup><br> <em><sup>1</sup>Gastroenterology and Hepatology, Saitama Medical University, Moroyama-Machi, <sup>2</sup>Yokohama Rosai Hospital for Labor Welfare Corporation, Yokohama, Japan. *kh0203forza@yahoo.co.jp</em></td><td valign=top><em>871 </td></tr> <tr> <td><a href='Abstract759.htm'><B>RETROVIRAL INSERTIONAL MUTAGENESIS IDENTIFIED THE SERINE-THREONINE KINASE RIPK4 AS PUTATIVE NOVEL TUMOR SUPPRESSOR IN HUMAN HEPATOCARCINOGENESIS</B></a> </em><br> <b>D. Heim</b><sup>1</sup>*, K. Cornils<sup>2</sup>, B. Fehse<sup>2</sup>, A.W. Lohse<sup>1</sup>, T.H. Brümmendorf<sup>3</sup>, H. Wege<sup>1</sup><br> <em><sup>1</sup>Gastroenterology and Hepatology, <sup>2</sup>Bone Marrow Transplantation Unit, University Medical Center Hamburg-Eppendorf, Hamburg, <sup>3</sup>Hematology and Oncology, University Medical Center Aachen, Aachen, Germany. *dheim@uke.de</em></td><td valign=top><em>872 </td></tr> <tr> <td><a href='Abstract760.htm'><B>ANGIOGENIC CHANGES IN A NEW MOUSE MODEL FOR HEPATOCELLULAR CARCINOMA ASSESSED WITH STATE-OF-THE-ART IMAGING TECHNOLOGY</B></a> </em><br> <b>F. Heindryckx</b><sup>1</sup>*, B. Vandeghinste<sup>2</sup>, C. Casteleyn<sup>3</sup>, N. Charette<sup>4</sup>, D. Slaets<sup>5</sup>, L. Libbrecht<sup>6</sup>, S. Staelens<sup>2</sup>, P. Stärkel<sup>4</sup>, A. Geerts<sup>1</sup>, I. Colle<sup>1</sup>, H. Van Vlierberghe<sup>1</sup><br> <em><sup>1</sup>Gastroenterology-Hepatology, Ghent University Hospital, <sup>2</sup>Medical Signal and Image Processing, <sup>3</sup>Veterinary Medicine - Morphology, Ghent University, Ghent, <sup>4</sup>Gastroenterology, Saint Luc University Hospital, Brussel, <sup>5</sup>Radiopharmacy, Ghent University, <sup>6</sup>Pathology, Ghent University Hospital, Ghent, Belgium. *femke.heindryckx@ugent.be</em></td><td valign=top><em>873 </td></tr> <tr> <td><a href='Abstract761.htm'><B>EPIGENETIC MODULATION OF TUMOUR SUPPRESSOR GADD45 BETA EXPRESSION BY HCV LEADS TO DEFECTIVE CELL CYCLE ARREST AND MAY PLAY A ROLE IN LIVER CARCINOGENESIS</B></a> </em><br> <b>M. Higgs</b>*, H. Lerat, J.-M. Pawlotsky<br> <em>Département de Virologie Moléculaire et Immunité, INSERM U955 (EQ.18) & Institut Mondor de Recherche Biomédicale, Creteil, France. *martin.higgs@inserm.fr</em></td><td valign=top><em>874 </td></tr> <tr> <td><a href='Abstract762.htm'><B>DETERMINATION OF GENETIC POLYMORPHISMS ASSOCIATED WITH METASTATIC TUMOR ANTIGEN 1 OVEREXPRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA</B></a> </em><br> <b>Y.-J. Jin</b><sup>1</sup>*, Y.-H. Chung<sup>1</sup>, J.A. Kim<sup>1</sup>, S.H. Lee<sup>2</sup>, D. Lee<sup>1</sup>, J.H. Shim<sup>1</sup>, E.-Y. Jo<sup>3</sup>, E.-S. Shin<sup>3</sup>, J.-E. Lee<sup>3</sup>, N.H. Park<sup>4</sup>, E. Yu<sup>5</sup>, Y.J. Lee<sup>6</sup><br> <em><sup>1</sup>Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, <sup>2</sup>Internal Medicine, Sooncheonhyang University College of Medicine, Cheonan Hospital, <sup>3</sup>DNA Link Inc., Seoul, <sup>4</sup>Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, <sup>5</sup>Pathology, <sup>6</sup>Hepato-Biliary and Pancreatic Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. *jyj412@hanmail.net</em></td><td valign=top><em>875 </td></tr> <tr> <td><a href='Abstract763.htm'><B>COFFEE MEDIATED UPREGULATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASES</B></a> </em><br> <b>S. Kalthoff</b>*, U. Ehmer, N. Freiberg, M. Manns, C. Strassburg<br> <em>Hannover Medical School, Hannover, Germany. *sandrakalthoff@hotmail.com</em></td><td valign=top><em>876 </td></tr> <tr> <td><a href='Abstract764.htm'><B>OBSERVATION OF MICROBUBBLES AND DETECTION OF HEPATOCYTES IN HEPATIC VEIN DURING RADIOFREQUENCY ABLATION</B></a> </em><br> <b>C. Kawamoto</b><sup>1</sup>*, K.-I. Manaka<sup>2</sup>, A. Yamauchi<sup>1</sup>, K. Kaneko<sup>1</sup>, K. Yakabi<sup>1</sup><br> <em><sup>1</sup>Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Kawagoe, <sup>2</sup>Institute of International Education and Research, Dokkyo Medical University, Mibu, Japan. *kawamoto.c@vesta.ocn.ne.jp</em></td><td valign=top><em>877 </td></tr> <tr> <td><a href='Abstract765.htm'><B>ALLOGENEIC ADOPTIVE IMMUNOTHERAPY OF THE HEPATOCELLULAR CARCINOMA BY INFUSION OF ''READY-TO-USE'' ALLOGENEIC SUICIDE GENE-MODIFIED T CELLS</B></a> </em><br> <b>C. Leboeuf</b><sup>1</sup>*, L. Mailly<sup>1</sup>, C. Ferrand<sup>2</sup>, P. Tiberghien<sup>2</sup>, P. Wolf<sup>3</sup>, M. Doffoel<sup>4</sup>, T.F. Baumert<sup>1</sup>, E. Robinet<sup>1</sup><br> <em><sup>1</sup>U748, INSERM U748, Strasbourg, <sup>2</sup>INSERM U645, Etablissement Français du Sang Bourgogne/Franche-Comte, Besançon, <sup>3</sup>Service de Chirurgie Digestive et Transplantation, <sup>4</sup>Service d'Hépato-Gastro-Enterologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. *celine.leboeuf@unistra.fr</em></td><td valign=top><em>878 </td></tr> <tr> <td><a href='Abstract766.htm'><B>PRECLINICAL STUDY OF NEW NANOPARTICLES WITH ANTICANCER AND MRI FUNCTIONS </B></a> </em><br> <b>J.W. Lee</b><sup>1</sup>*, J.I. Lee<sup>1</sup>, D.H. Lee<sup>2</sup>, Y.S. Kim<sup>2</sup>, S.-S. Hong<sup>2</sup>, J.-H. Maeng<sup>2</sup>, K.-H. Jung<sup>2</sup><br> <em><sup>1</sup>Internal Medicine, <sup>2</sup>Inha University School of Medicine, Incheon, Republic of Korea. *jin@inha.ac.kr</em></td><td valign=top><em>879 </td></tr> <tr> <td><a href='Abstract767.htm'><B>ESTROGEN RECEPTOR ² SELECTIVE AGONISTS EXERT ANTI-CANCER ACTIVITY ON EXPERIMENTAL INTRA-HEPATIC CHOLANGIOCARCINOMA: AN IN VITRO AND IN VIVO STUDY</B></a> </em><br> <b>M. Marzioni</b><sup>1</sup>*, S. Saccomanno<sup>1</sup>, A. Torrice<sup>2</sup>, C. Rychlicki<sup>1</sup>, L. Agostinelli<sup>1</sup>, P. Rhönnstad<sup>3</sup>, L. Trozzi<sup>1</sup>, T. Apelqvist<sup>3</sup>, C. Candelaresi<sup>1</sup>, G. Fava<sup>1</sup>, A. Benedetti<sup>1</sup>, E. Gaudio<sup>4</sup>, E. Kallin<sup>3</sup>, D. Alvaro<sup>2</sup>, S. Nilsson<sup>3</sup><br> <em><sup>1</sup>Gastroenterology, Università Politecnica delle Marche, Ancona, <sup>2</sup>Gastroenterology, Polo Pontino, Universià degli Studi  La Sapienza , Roma, Italy, <sup>3</sup>Karo Bio AB, Huddinge, Sweden, <sup>4</sup>Institute of Human Anatomy, Universià degli Studi  La Sapienza , Roma, Italy. *m.marzioni@univpm.it</em></td><td valign=top><em>880 </td></tr> <tr> <td><a href='Abstract768.htm'><B>COMBINATION THERAPY WITH EGFR1-2/VEGFR INHIBITOR (XL647) AND SORAFENIB IMPROVES OUTCOMES IN A PRE-CLINICAL MODEL OF HCC</B></a> </em><br> <b>B. Mínguez</b><sup>1</sup>*, S. Toffanin<sup>1</sup>, A. Lachenmayer<sup>1</sup>, L. Cabellos<sup>1</sup>, A. Villanueva<sup>2</sup>, A. DiFeo<sup>3</sup>, P. Melgar-Lesmes<sup>4</sup>, S. Thung<sup>1</sup>, S.L. Friedman<sup>1</sup>, J.M. Llovet<sup>1,2,5</sup><br> <em><sup>1</sup>Liver Cancer Program. Division of Liver Diseases, Mount Sinai School of Medicine, Mount Sinai Medical Center, New York, NY, USA, <sup>2</sup>BCLC Group, Liver Unit, IDIBAPS, CIBERehd, Hospital Clínic, Barcelona, Spain, <sup>3</sup>Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, Mount Sinai Medical Center, New York, NY, USA, <sup>4</sup>Biochemistry and Molecular Genetics, IDIBAPS, CIBERehd, Hospital Clínic, <sup>5</sup>Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. *beatriz.minguez@mssm.edu</em></td><td valign=top><em>881 </td></tr> <tr> <td><a href='Abstract769.htm'><B>TUMOR LYMPHOCYTIC INFILTRATE: A PREDICTOR OF DISEASE FREE SURVIVAL AFTER RESECTION FOR HCC</B></a> </em><br> E. Cariani<sup>1</sup>, M. Pilli<sup>2</sup>, A. Zerbini<sup>2</sup>, A. Olivani<sup>2</sup>, C. Rota<sup>1</sup>, G. Pelosi<sup>2</sup>, P. Soliani<sup>3</sup>, E.M. Silini<sup>4</sup>, C. Ferrari<sup>2</sup>, <b>G. Missale</b><sup>2</sup>*<br> <em><sup>1</sup>Laboratorio di Tossicologia, Ospedale Civile S. Agostino-Estense, Modena, <sup>2</sup>Malattie Infettive ed Epatologia, Azienda Ospedaliero-Universitaria di Parma, <sup>3</sup>Clinica Chirurgica e dei Trapianti d'Organo, <sup>4</sup>Istituto di Anatomia Patologica, Università degli Studi di Parma, Parma, Italy. *missale@tin.it</em></td><td valign=top><em>882 </td></tr> <tr> <td><a href='Abstract770.htm'><B>THE PIVOTAL ROLE OF HEPATIC-STELLATE-CELLS IN THE <I>IN-VIVO</I> AND <I>IN-VITRO</I> HEPATOCELLULAR CARCINOMA MODELS</B></a> </em><br> <b>N. Muhanna</b>*, L. Abu Tair, S. Doron, J. Amer, R. Safadi<br> <em>Liver Unit, Gastroenterology Institute, Division of Medicine, Hadassah University Medical Center, Jerusalem, Israel. *safadi@hadassah.org.il</em></td><td valign=top><em>883 </td></tr> <tr> <td><a href='Abstract771.htm'><B>CXCL1 RS4074 POLYMORPHISM INFLUENCES THE SUSCEPTIBILITY TO HEPATOCELLULAR CARCINOMA</B></a> </em><br> <b>H.D. Nischalke</b><sup>1</sup>*, M. Coenen<sup>1</sup>, C. Berger<sup>1</sup>, T. Müller<sup>2</sup>, T. Berg<sup>2</sup>, C. Luda<sup>1</sup>, B. Krämer<sup>1</sup>, D. Schulte<sup>1</sup>, C. Körner<sup>1</sup>, J. Nattermann<sup>1</sup>, T. Sauerbruch<sup>1</sup>, U. Spengler<sup>1</sup><br> <em><sup>1</sup>Medizinische Klinik und Poliklinik I, Universität Bonn, Bonn, <sup>2</sup>Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charité, Universitätsmedizin Berlin, Berlin, Germany. *nischalke@uni-bonn.de</em></td><td valign=top><em>884 </td></tr> <tr> <td><a href='Abstract772.htm'><B>ALBUMIN SUPPRESSES HUMAN HEPATOCELLULAR CARCINOMA PROLIFERATION AND THE CELL CYCLE</B></a> </em><br> <b>S. Nojiri</b>*, T. Miyaki, K. Senda, N. Shinkai, A. Kusakabe, K. Matsuura, E. Iio, T. Joh<br> <em>Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. *snojiri@med.nagoya-cu.ac.jp</em></td><td valign=top><em>885 </td></tr> <tr> <td><a href='Abstract773.htm'><B>HTERT PROMOTER GENE POLYMORPHISM AND THE RISK OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH CHRONIC HEPATITIS B</B></a> </em><br> <b>J.Y. Park</b><sup>1,2</sup>*, H.Y. Chang<sup>2</sup>, S.H. Ahn<sup>1,2</sup>, J.M. Lee<sup>1,2</sup>, D.Y. Kim<sup>1,2</sup>, K.S. Lee<sup>1,2</sup>, C.Y. Chon<sup>1,2</sup>, Y.M. Moon<sup>3</sup>, K.-H. Han<sup>1,2</sup><br> <em><sup>1</sup>Internal Medicine, Yonsei University College of Medicine, <sup>2</sup>Liver Cirrhosis Clinical Research Center, Seoul, <sup>3</sup>Internal Medicine, Kwan Dong University College of Medicine, Goyang, Republic of Korea. *drpjy@yuhs.ac</em></td><td valign=top><em>886 </td></tr> <tr> <td><a href='Abstract774.htm'><B>FORKHEAD BOX M1B IS A DETERMINANT OF RAT SUSCEPTIBILITY TO HEPATOCARCINOGENESIS AND SUSTAINS ERK ACTIVITY IN HUMAN HCC</B></a> </em><br> <b>R.M. Pascale</b>*, M.M. Simile, M. Frau, D. Calvisi, M.L. Tomasi, M.A. Seddaiu, F. Feo<br> <em>BioMedical Sciences, University, Sassari, Italy. *patsper@uniss.it</em></td><td valign=top><em>887 </td></tr> <tr> <td><a href='Abstract775.htm'><B>CAP-INDEPENDENT TRANSLATION OF LAMININ B1 DURING LIVER CANCER PROGRESSION</B></a> </em><br> <b>M. Petz</b>*, M. Hau, H. Huber, W. Mikulits<br> <em>Department of Medicine I, Division - Institute of Cancer Research, Medical University of Vienna, Vienna, Austria. *michaela.petz@meduniwien.ac.at</em></td><td valign=top><em>888 </td></tr> <tr> <td><a href='Abstract776.htm'><B>CHEMOEMBOLIZATION WITH DRUG-ELUTING BEADS: RESULTS OF A COMPARISON STUDY BETWEEN HEPASPHERES"! AND DC BEADS "! LOADED WITH EPIRUBICIN</B></a> </em><br> <b>G. Poggi</b><sup>1</sup>*, C. Sottani<sup>2</sup>, E. Leoni<sup>2</sup>, P. Quaretti<sup>3</sup>, A. Amatu<sup>4</sup>, B. Porro<sup>2</sup>, B. Montagna<sup>4</sup>, B. Tagliaferri<sup>4</sup>, F. Sottotetti<sup>4</sup>, F. Zappoli<sup>3</sup>, G. Bernardo<sup>4</sup>, C. Minoia<sup>2</sup><br> <em><sup>1</sup>Hepato-oncology, <sup>2</sup>Laboratory of Enviromental and Toxicological Testing, IRCCS Fondazione Maugeri, <sup>3</sup>Interventional Radiology, IRCCS Pol. S. Matteo, <sup>4</sup>Oncology, IRCCS Fondazione Maugeri, Pavia, Italy. *guido.poggi@fsm.it</em></td><td valign=top><em>889 </td></tr> <tr> <td><a href='Abstract777.htm'><B>HETEROGENEITY IN PRIMARY HUMAN HEPATOCELLULAR CARCINOMA IS DUE TO DIFFERENT SUBSETS OF CANCER STEM-LIKE CELLS WITHIN THE TUMOUR</B></a> </em><br> F. Baldan<sup>1</sup>, S. Mazzucchelli<sup>1</sup>, F. Colombo<sup>1</sup>, I. Martin-Padura<sup>2</sup>, A. Cattaneo<sup>1</sup>, G. Rossi<sup>3</sup>, V. Mazzaferro<sup>4</sup>, B. Foglieni<sup>5</sup>, F. Bertolini<sup>2</sup>, D. Prati<sup>5</sup>, <b>L. Porretti</b><sup>1</sup>*<br> <em><sup>1</sup>Center of Transfusion Medicine, Cellular Therapy and Cryobiology, IRCSS Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, <sup>2</sup>Hemato-oncology Department, European Oncology Institute, <sup>3</sup>Liver Transplant Unit, IRCCS Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, <sup>4</sup>Gastroenterology Surgery Department, National Cancer Institute, Milan, <sup>5</sup>Department of Transfusion Medicine and Hematology, Ospedale A. Manzoni, Lecco, Italy. *l.porretti@policlinico.mi.it</em></td><td valign=top><em>890 </td></tr> <tr> <td><a href='Abstract778.htm'><B>PLASMINOGEN K1-5 STRONGLY REDUCES TUMOUR GROWTH VIA DUAL ANTIANGIOGENIC AND ANTITUMOURAL EFFECTS <I>IN VITRO</I> AND <I>IN VIVO</I></B></a> </em><br> <b>E. Raskopf</b>*, A. Vogt, T. Sauerbruch, V. Schmitz<br> <em>Department of Inner Medicine I, University Clinic of Bonn, Bonn, Germany. *esther.raskopf@ukb.uni-bonn.de</em></td><td valign=top><em>891 </td></tr> <tr> <td><a href='Abstract779.htm'><B>ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS</B></a> </em><br> <b>E. Rovida</b><sup>1</sup>*, N. Navari<sup>1</sup>, S. Cannito<sup>2</sup>, P. Dello Sbarba<sup>1</sup>, M. Parola<sup>2</sup>, F. Marra<sup>1</sup><br> <em><sup>1</sup>University of Florence, Florence, <sup>2</sup>University of Turin, Turin, Italy. *elisabetta.rovida@unifi.it</em></td><td valign=top><em>892 </td></tr> <tr> <td><a href='Abstract780.htm'><B>SERIAL DECREASE OF PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS AFTER TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION MAY PREDICT EFFECTIVENESS OF PROCEDURE; A PROSPECTIVE STUDY</B></a> </em><br> <b>S.H. Ryu</b><sup>1</sup>*, J.H. Park<sup>1</sup>, H.H. Kim<sup>1</sup>, J.A. Kim<sup>2</sup>, J.H. Lee<sup>1</sup>, Y.S. Kim<sup>1</sup>, J.S. Moon<sup>1</sup><br> <em><sup>1</sup>Division of Gastroenterology, Department of Internal Medicine, University of Inje College of Medicine, Seoul Paik Hospital, Seoul, Korea, <sup>2</sup>Division of Gastroenterology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. *rshdrryu@medimail.co.kr</em></td><td valign=top><em>893 </td></tr> <tr> <td><a href='Abstract781.htm'><B>ALPHA-FETOPROTEIN CAN BE USED AS A PANCREATIC CANCER STEM CELL MARKER</B></a> </em><br> <b>N. Sasaki</b>*, T. Ishii, K. Yasuchika, R. Kamimura, R. Doi, S. Uemoto, Department of Surgery, Kyoto University<br> <em>Department of Surgery, Graduate School of Medecine, Kyoto University, Kyoto, Japan. *naoya@kuhp.kyoto-u.ac.jp</em></td><td valign=top><em>894 </td></tr> <tr> <td><a href='Abstract782.htm'><B>A PRO- AND ANTI-ONCOGENIC ROLE OF STAT3 IN HEPATOCELLULAR CARCINOMA PROGRESSION</B></a> </em><br> <b>D. Schneller</b><sup>1</sup>*, G. Machat<sup>1</sup>, F. Van Zijl<sup>1</sup>, G. Zulehner<sup>1</sup>, V. Proell<sup>1</sup>, H. Huber<sup>1</sup>, M. Mair<sup>2</sup>, S. Nijman<sup>3</sup>, R. Eferl<sup>2</sup>, R. Moriggl<sup>2</sup>, W. Mikulits<sup>1</sup><br> <em><sup>1</sup>Department of Medicine I, Institut of Cancer Research/Medical University of Vienna, <sup>2</sup>The Ludwig Boltzmann Institute for Cancer Research, <sup>3</sup>Research Center of Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. *doris.schneller@meduniwien.ac.at</em></td><td valign=top><em>895 </td></tr> <tr> <td><a href='Abstract783.htm'><B>HEPACAM, A NEW</B><B> IG-LIKE CELL ADHESION MOLECULE </B><B>INDENTIFIED IN THE LIVER</B></a> </em><br> <b>S. Shen</b>*<br> <em>Physiology, National University of Singapore, Medical Drive, Singapore. *phsssl@nus.edu.sg</em></td><td valign=top><em>896 </td></tr> <tr> <td><a href='Abstract784.htm'><B>INCREASED INTERLEUKIN-17-PRODUCING CD4 T CELLS CORRELATE WITH DISEASE PROGRESSION IN HEPATOCELLULAR CARCINOMA PATIENTS</B></a> </em><br> <b>M. Shi</b>*, F. Shi, J.-Y. Zhang, L.-M. Chen, F.-S. Wang<br> <em>Beijing Institute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. *shiming302@sina.com</em></td><td valign=top><em>897 </td></tr> <tr> <td><a href='Abstract785.htm'><B>CLOSE ASSOCIATION OF ARREST DEFECTIVE PROTEIN 1 MRNA OVEREXPRESSION WITH MICROVASCULAR INVASION <B>IN </B>HEPATOCELLULAR CARCINOMA</B></a> </em><br> <b>J.H. Shim</b><sup>1</sup>*, Y.-H. Chung<sup>1</sup>, J.A. Kim<sup>1</sup>, D.-J. Yoo<sup>1</sup>, Y.-J. Jin<sup>1</sup>, D. Lee<sup>1</sup>, D.D. Seo<sup>2</sup>, S.H. Kim<sup>3</sup>, S.H. Ryu<sup>4</sup>, S.H. Yang<sup>3</sup>, E. Yu<sup>5</sup>, Y.J. Lee<sup>6</sup><br> <em><sup>1</sup>Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, <sup>2</sup>Internal Medicine, University of Inje College of Medicine, Sanggye Paik Hospital, <sup>3</sup>Internal Medicine, Korea Veterans' Hospital, <sup>4</sup>Internal Medicine, University of Inje College of Medicine, Seoul Paik Hospital, <sup>5</sup>Pathology, <sup>6</sup>Hepato-Biliary and Pancreatic Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. *s5854@medimail.co.kr</em></td><td valign=top><em>898 </td></tr> <tr> <td><a href='Abstract786.htm'><B>MICRORNA EXPRESSION OF KERATIN 19 POSITIVE HEPATOCELLULAR CARCINOMAS INDICATES STRONG TUMOUR PROGRESSION AND INVASION</B></a> </em><br> O. Govaere<sup>1</sup>, <b>B. Spee</b><sup>1</sup>*, C. Verslype<sup>2</sup>, R. Aerts<sup>3</sup>, B. Topal<sup>3</sup>, F. Nevens<sup>2</sup>, T. Roskams<sup>1</sup><br> <em><sup>1</sup>Department of Morphology and Molecular Pathology, Katholieke Universiteit Leuven, <sup>2</sup>Department of Hepatology, <sup>3</sup>Department of Abdominal Surgery, University Hospital Gasthuisberg, Leuven, Belgium. *b.spee@uu.nl</em></td><td valign=top><em>899 </td></tr> <tr> <td><a href='Abstract787.htm'><B>COMMON HCC CELL LINES REPRESENT ONLY A SUBGROUP OF HUMAN HCC CASES</B></a> </em><br> <b>F. Staib</b>*, M. Karakus, M. Krupp, T. Maass, P.R. Galle, A. Teufel<br> <em>I. Department of Internal Medicine, Johannes Gutenberg-University Mainz, Mainz, Germany. *staib.f@gmx.de</em></td><td valign=top><em>900 </td></tr> <tr> <td><a href='Abstract788.htm'><B>COMPARATIVE GENOMICS ANALYSIS OF HEPATIC ADENOMA, NORMAL LIVER, AND HCC REVEALED CLOSER RELATIONSHIP OF ADENOMA TO HCC WITH FAVORABLE OUTCOME</B></a> </em><br> <b>F. Staib</b>*, M. Karakus, M. Krupp, T. Maass, P.R. Galle, A. Teufel<br> <em>I. Department of Internal Medicine, Johannes Gutenberg-University Mainz, Mainz, Germany. *staib.f@gmx.de</em></td><td valign=top><em>901 </td></tr> <tr> <td><a href='Abstract789.htm'><B>THE P53 FAMILY TARGET GENE SIGNATURE IS OF PROGNOSTIC RELEVANCE IN HEPATOCELLULAR CARCINOMA</B></a> </em><br> <b>F. Staib</b><sup>1</sup>*, H. Mundt<sup>2</sup>, A. Koch<sup>2</sup>, M. Krupp<sup>1</sup>, P.R. Galle<sup>1</sup>, W. Stremmel<sup>2</sup>, A. Teufel<sup>1</sup>, M. Müller<sup>2</sup><br> <em><sup>1</sup>I. Department of Internal Medicine, Johannes Gutenberg-University Mainz, Mainz, <sup>2</sup>IV Department of Medicine, Ruprecht Karls University Heidelberg, Heidelberg, Germany. *staib.f@gmx.de</em></td><td valign=top><em>902 </td></tr> <tr> <td><a href='Abstract790.htm'><B>FRACTAL ANALYSIS DIFFERENTIATION OF NUCLEAR AND VASCULAR PATTERNS IN HEPATOCELLULAR CARCINOMAS AND HEPATIC METASTASIS</B></a> </em><br> <b>C.T. Streba</b><sup>1</sup>*, D. Pirici<sup>2</sup>, L. Mogoanta<sup>2</sup>, M. Comanescu<sup>2</sup>, I. Rogoveanu<sup>1</sup>, L. Sandulescu<sup>1</sup>, A. Bold<sup>2</sup><br> <em><sup>1</sup>Medical Clinic I, <sup>2</sup>University of Medicine and Pharmacy of Craiova, Craiova, Romania. *costinstreba@gmail.com</em></td><td valign=top><em>903 </td></tr> <tr> <td><a href='Abstract791.htm'><B>INCREASED EXPRESSION OF FAT1 IN HEPATOCELLULAR CARCINOMA PROMOTES TUMORIGENICITY</B></a> </em><br> <b>D. Valletta</b><sup>1</sup>*, T. Amann<sup>1</sup>, A.K. Bosserhoff<sup>2</sup>, C. Hellerbrand<sup>1</sup><br> <em><sup>1</sup>University Hospital Regensburg, <sup>2</sup>University Regensburg, Regensburg, Germany. *daniela.valletta@klinik.uni-regensburg.de</em></td><td valign=top><em>904 </td></tr> <tr> <td><a href='Abstract792.htm'><B>A UNIQUE HUMAN MODEL OF EPITHELIAL TO MESENCHYMAL TRANSITION REVEALS AXL AS A KEY REGULATOR OF HEPATOCELLULAR CARCINOMA PROGRESSION</B></a> </em><br> <b>F. van Zijl</b><sup>1</sup>*, S. Mall<sup>1</sup>, G. Machat<sup>1</sup>, T. Bauer<sup>2</sup>, C. Pirker<sup>1</sup>, H. Strobl<sup>2</sup>, W. Berger<sup>1</sup>, M. Bilban<sup>3</sup>, W. Mikulits<sup>1</sup><br> <em><sup>1</sup>Inner Medicine I, Division - Institute of Cancer Research, <sup>2</sup>Vienna Competence Center, Institute of Immunology, <sup>3</sup>Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University Vienna, Vienna, Austria. *franziska.vanzijl@meduniwien.ac.at</em></td><td valign=top><em>905 </td></tr> <tr> <td><a href='Abstract793.htm'><B>INHIBITION OF TUMOR GROWTH AFTER SUBCUTANEOUS INJECTION OF DENDRITIC CELLS ENGINEERED TO EXPRESS ANGIOGENESIS-RELATED FLK-1 ANTIGEN IN A MURINE HCC MODEL</B></a> </em><br> <b>A. Vogt</b><sup>1</sup>*, G. Decker<sup>1</sup>, E. Raskopf<sup>1</sup>, V. Schmitz<sup>1</sup>, T. Sauerbruch<sup>1</sup>, W.H. Caselmann<sup>2</sup>, M.A. González-Carmona<sup>1</sup><br> <em><sup>1</sup>Internal Medicine, University of Bonn, Bonn, <sup>2</sup>Ministry of the Environment and Public Health, Bavarian State, Munich, Germany. *annabelle.vogt@ukb.uni-bonn.de</em></td><td valign=top><em>906 </td></tr> <tr> <td><a href='Abstract794.htm'><B>SIRNA TARGETING TO HEPATITIS B VIRUS X AND </B><B>5-AZA-DC</B><B> INHIBIT GROWTH OF HEPATOCELLULAR CARCINOMA CELLS <I>IN VITRO </I>AND <I>VIVO</I> VIA RESCUING P16 FUNCTIONS</B></a> </em><br> <b>L. Yang</b><sup>1</sup>*, J.Y. Kuang<sup>1</sup>, X. Wang<sup>2</sup>, J.Y. Zhu<sup>1</sup>, X.B. Yao<sup>1</sup>, Y.T. Chong<sup>1</sup>, Q.F. Xie<sup>1</sup>, Z.L. Gao<sup>1</sup><br> <em><sup>1</sup>Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, <sup>2</sup>Department of Infectious Diseases, the Second Peopl's Hospital of Shenzhen City, Shenzhen, China. *linyang1962@hotmail.com</em></td><td valign=top><em>907 </td></tr> <tr> <td><a href='Abstract795.htm'><B>RELATIONSHIP OF INSULIN-LIKE GROWTH FACTORS SYSTEM GENE POLYMORPHISMS WITH SUSCEPTIBILITY AND PATHOLOGICAL DEVELOPMENT OF HEPATOCELLULAR CARCINOMA</B></a> </em><br> <b>S.-F. Yang</b><sup>1,2</sup>*, Y.-H. Chu<sup>1</sup>, H.-L. Chiou<sup>3</sup><br> <em><sup>1</sup>Institute of Medicine, Chung Shan Medical University, <sup>2</sup>Department of Medical Research, Chung Shan Medical University Hospital, <sup>3</sup>School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan R.O.C.. *ysf@csmu.edu.tw</em></td><td valign=top><em>908 </td></tr> <tr> <td><a href='Abstract796.htm'><B>14-3-3¶ IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA AND ITS SUPPRESSION INHIBITS TUMOR GROWTH AND ENHANCES CHEMOSENSITIVITY</B></a> </em><br> <b>S.K. Yoon</b><sup>1</sup>*, J.E. Choi<sup>2</sup>, S.W. Lee<sup>1</sup>, M.J. Song<sup>1</sup>, S.H. Bae<sup>1</sup>, J.Y. Choi<sup>1</sup>, J.M. Yang<sup>1</sup>, Y.S. Lee<sup>1</sup>, C.D. Lee<sup>1</sup>, K.W. Chung<sup>1</sup><br> <em><sup>1</sup>Internal Medicine, College of Medicine, The Catholic University of Korea, <sup>2</sup>WHO Collaborating Center of Viral Hepatitis, Seoul, Republic of Korea. *mjsong95@catholic.ac.kr</em></td><td valign=top><em>909 </td></tr> <tr> <td><a href='Abstract797.htm'><B>CANCER STEM CELL ACTIVATION IN HCC AFTER TRANS-ARTERIAL CHEMOEMBOLIZATION (TACE)</B></a> </em><br> <b>C. Zen</b><sup>1</sup>*, Y. Zen<sup>1</sup>, R.R. Mitry<sup>1</sup>, D. Corbeil<sup>2</sup>, J. Karbanova<sup>2</sup>, J. O'grady<sup>1</sup>, N. Heaton<sup>1</sup>, B. Portmann<sup>1</sup>, A. Quaglia<sup>1</sup><br> <em><sup>1</sup>Institute of Liver Studies, King's College Hospital, London, UK, <sup>2</sup>Tissue Engineering Laboratories, BIOTEC and DFG Research Center and Cluster of Excellence for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany. *cishihara616@yahoo.co.jp</em></td><td valign=top><em>910 </td></tr> </table><a href='index.asp'>Back</a><br> <p>&nbsp;</p> <p>&nbsp;</p></td> </tr> </table> </body> </html>